National Institute of Mental Health; Notice of Closed Meeting, 42311-42312 [E9-20152]

Download as PDF Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–D–0346] Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Tomatoes; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. The Food and Drug Administration is correcting a notice that appeared in the Federal Register of August 3, 2009 (74 FR 38438). The document announced the availability of a draft guidance entitled ‘‘Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Tomatoes.’’ The document was published with an incorrect date for submitting written or electronic comments on the draft guidance. This document corrects that error. SUMMARY: FOR FURTHER INFORMATION CONTACT: Michelle A. Smith, Center for Food Safety and Applied Nutrition (HFS– 317), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301–436–2024. SUPPLEMENTARY INFORMATION: In FR Doc. E9–18453, appearing on page 38438 in the Federal Register of August 3, 2009, the following correction is made: 1. On page 38438, in the third column, in the ‘‘DATES’’ section, in the eighth line, ‘‘October 2, 2009’’ is corrected to read ‘‘November 2, 2009’’. Dated: August 17, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–20103 Filed 8–20–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–D–0347] srobinson on DSKHWCL6B1PROD with NOTICES Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Melons; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration is correcting a notice that appeared in the Federal Register of August 3, 2009 (74 FR 38437). The VerDate Nov<24>2008 16:22 Aug 20, 2009 Jkt 217001 document announced the availability of a draft guidancet entitled ‘‘Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Melons.’’ The document was published with an incorrect date for submitting written or electronic comments on the draft guidance. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Willette Crawford, Center for Food Safety and Applied Nutrition (HFS– 317), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301–436–1111. SUPPLEMENTARY INFORMATION: In FR Doc. E9–18452, appearing on page 38437 in the Federal Register of Wednesday, August 3, 2009, the following correction is made: On page 38437, in the third column, in the DATES section, in the eighth line, ‘‘October 2, 2009’’ is corrected to read ‘‘November 2, 2009’’. Dated: August 17, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–20102 Filed 8–20–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–D–0348] Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Leafy Greens; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration is correcting a notice that appeared in the Federal Register of August 3, 2009 (74 FR 38439). The document announced the availability of a draft guidance entitled ‘‘Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Leafy Greens.’’ The document was published with an incorrect date for submitting written or electronic comments on the draft guidance. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Amy Green, Center for Food Safety and Applied Nutrition (HFS–317), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301– 436–2025. SUPPLEMENTARY INFORMATION: In FR Doc. E9–18451, appearing on page 38439 in PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 42311 the Federal Register of August 3, 2009, the following correction is made: 1. On page 38439, in the third column, in the ‘‘DATES’’ section, in the eighth line, ‘‘October 2, 2009’’ is corrected to read ‘‘November 2, 2009’’. Dated: August 17, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–20101 Filed 8–20–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; ARRA Studies Involving Human Embryonic Stem Cells. Date: August 28, 2009. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call) Contact Person: David W Miller, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–9734, millerda@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS) E:\FR\FM\21AUN1.SGM 21AUN1 42312 Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices Dated: August 13, 2009. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–20152 Filed 8–20–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Meeting; Moving Into the Future—New Dimensions and Strategies for Women’s Health Research for the National Institutes of Health Notice is hereby given that the Office of Research on Women’s Health (ORWH), Office of the Director, National Institutes of Health, Department of Health and Human Services, in collaboration with Northwestern University’s Feinberg School of Medicine and Northwestern Memorial Hospital, will convene a public hearing and scientific workshop on October 14– 16, 2009, at Northwestern University, Thorne Auditorium, Arthur Rubloff Building, Chicago, Illinois. srobinson on DSKHWCL6B1PROD with NOTICES Purpose of the Meeting With rapid advances in science and wider global understanding of women’s health and sex/gender contributions to well-being and disease, the purpose of the meeting is to ensure that NIH continues to support cutting-edge women’s health research that is based upon the most advanced techniques and methodologies. The meeting format is designed to promote an interactive discussion involving leading scientists, advocacy groups, public policy experts, health care providers, and the general public. The Chicago meeting is the fourth in a series that will be convened throughout the Nation to help the ORWH and NIH move into the next decade of women’s health research. As science and technology advance and fields such as computational biology demonstrate the power of interdisciplinary research, it remains critical for sex and gender factors to be integrated into broad experimental methodologies and scientific approaches across the lifespan. Biomedical and behavioral research are also necessary to understand how cultural, ethnic, and racial differences influence the causes, diagnosis, progression, treatment, and outcome of disease among different populations, including women of diverse geographic locations and socioeconomic backgrounds. Furthermore, the fact that VerDate Nov<24>2008 16:22 Aug 20, 2009 Jkt 217001 there are health differences among diverse populations of women remains a critical area in need of continued focus and attention. The ORWH challenges all meeting attendees to assist the NIH in defining the women’s health research agenda of the future by thinking beyond traditional women’s health issues. The ORWH and NIH ask meeting participants to consider creative strategies to identify areas of research that are best poised for advancement, identify innovative ways in which persistent issues of health and disease can be addressed, and explore new horizons of scientific concepts and investigative approaches. Attention also needs to be paid to new areas of science application, new technologies, and continuing basic science investigations. Clinical questions that are not currently the focus of research priorities need to be considered to ensure that women’s health research is optimally served and that the ORWH can continue to provide leadership for the benefit of women’s health, nationally and internationally. Meeting Format The meeting will consist of public testimony, scientific panels and seven concurrent scientific working groups. Specifically, on October 14, individuals representing a full spectrum of organizations interested in biomedical and behavioral research on women’s health issues will have an opportunity to provide public testimony from 2 to 6 p.m. On October 15 and 16, plenary sessions will focus on the intersection of health care, public policy, and biomedical research; on emerging issues and trends in health care; and on research paradigms of the future. The seven concurrent afternoon sessions on October 15 will focus on a range of research areas, including preventive heath and special populations; clinical trials/research; new technologies, bioengineering, imaging; genetics/ epigenetics; sex hormones and disease; neuroscience; and women in science careers. On October 16, the morning session will be devoted to reports by the working group co-chairs regarding the recommendations emerging from working group deliberations on the previous day. The meeting will adjourn at 12:45 p.m. on October 16. Public Testimony The ORWH invites individuals with an interest in research related to women’s health to provide written and/ or oral testimony on these topics and/ or on issues related to the sustained advancement of women in various biomedical careers. Due to time PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 constraints, only one representative from an organization or professional specialty group may give oral testimony. Individuals not representing an organized entity but a personal point of view are similarly invited to present written and/or oral testimony. A letter of intent to present oral testimony is necessary and should be sent electronically to https:// www.orwhmeetings.com/ movingintothefuture/ or by mail to Ms. Jory Barone, Educational Services, Inc., 4350 East-West Highway, Suite 1100, Bethesda, MD 20814, no later than October 4, 2009. The date of receipt of the communication will establish the order of those selected to give oral testimony at the October meeting. Those wishing to present oral testimony are also asked to submit a written form of their testimony that is limited to a maximum of 10 pages, double spaced, 12 point font, and should include a brief description of the organization. Electronic submission to the above Web site is preferred; however, for those who do not have access to electronic means, written testimony, bound by the restrictions previously noted and postmarked no later than October 4, 2009, can be mailed to Ms. Jory Barone at the above address. All written presentations must meet the established page limitations. Submissions exceeding this limit will not be accepted and will be returned. Oral testimony of this material at the meeting will be limited to no more than 5–6 minutes in length. Because of time constraints for oral testimony, testifiers may not be able to present the complete information as it is contained in their written form submitted for inclusion in the public record for the meeting. Therefore, testifiers are requested to summarize the major points of emphasis from the written testimony, not to exceed 6 minutes of oral testimony. Those individuals or organizations that have indicated they will present oral testimony at the meeting in Chicago will be notified prior to the meeting regarding the approximate time for their oral presentation. Individuals and organizations wishing to provide written statements only should send a copy of their statements, electronically or by mail, to the above Web site or address by October 4, 2009. Written testimony received by that date will be made available at the October 14–16 meeting. Logistics questions related to the meeting should be addressed to Ms. Jory Barone at ESI, while program-specific questions should be addressed to Dr. Jody K. Hirsch at the Feinberg School of E:\FR\FM\21AUN1.SGM 21AUN1

Agencies

[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Pages 42311-42312]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20152]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; ARRA Studies Involving Human Embryonic Stem Cells.
    Date: August 28, 2009.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call)
    Contact Person: David W Miller, PhD, Scientific Review Officer, 
Division of Extramural Activities, National Institute of Mental 
Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, 
MSC 9608, Bethesda, MD 20892-9608, 301-443-9734, 
millerda@mail.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, 
Mental Health Research Grants; 93.281, Scientist Development Award, 
Scientist Development Award for Clinicians, and Research Scientist 
Award; 93.282, Mental Health National Research Service Awards for 
Research Training; 93.701, ARRA Related Biomedical Research and 
Research Support Awards, National Institutes of Health, HHS)


[[Page 42312]]


    Dated: August 13, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-20152 Filed 8-20-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.